1. Zuckerberg San Francisco General Hospital and Trauma Center, Division of Hematology-Oncology, Department of Medicine, University of California at San Francisco, San Francisco
2. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
3. Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) at Complutense University of Madrid, Madrid, Spain